Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.
NVS Key Statistics
NVS News
Key Points The Swiss drugmaker announced its biggest deal in a decade on Sunday, as its set to buy Avidity Biosciences for about $12 billion. "We have adequate...
Novartis confirmed its full-year guidance. fabrice coffrini/Agence France-Presse/Getty Images Novartis NOVN -0.88 %decrease; red down pointing triangle posted...
(RTTNews) - Swiss drug major Novartis AG (NVS) reported Tuesday higher net income in its third quarter, benefited by sales growth above market estimates. Lookin...
Analyst ratings
65%
of 26 ratingsMore NVS News
Avidity Biosciences, Inc. (NASDAQ:RNA) stock surged after announcing a $12 billion all-cash acquisition by Novartis AG (NYSE:NVS), marking one of the largest bi...
Morgan Stanley raised the firm’s price target on Novartis (NVS) to CHF 108 from CHF 105 and keeps an Equal Weight rating on the shares. Elevate Your Investing...
Close Key Takeaways Novartis is buying Avidity Biosciences in an all-cash deal valued at $12 billion to access Avidity's experimental treatments for neuromuscu...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
In a report released today, Sachin Jain from Bank of America Securities maintained a Hold rating on Novartis AG, with a price target of CHF111.00. Elevate Your...
Avidity Biosciences, Inc. (NASDAQ:RNA) shares are rocketing premarket on Monday. On Sunday, the company agreed to merge with Novartis AG (NYSE:NVS) in a deal va...
Swiss pharmaceutical giant Novartis AG (NVS) has agreed to acquire American biotech firm Avidity Biosciences (RNA) for roughly $12 billion in an all-cash deal....